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Abstract 
Background: Although outcomes of critically ill patients with haematological malignancies (HMs) have been fully 
investigated in terms of organ failure and mortality, data are scarce on health‑related quality of life (HRQOL) in this 
population. We aim to assess post‑intensive care unit (ICU) burden and HRQOL of critically ill patients with HMs and to 
identify risk factors for quality‑of‑life (QOL) impairment.
Results: In total, 1011 patients with HMs who required ICU admission in 17 ICUs in France and Belgium were 
included in the study; 278 and 117 patients were evaluated for QOL at 3 months and 1 year, respectively, after ICU 
discharge. HRQOL was determined by applying the interview form of the Short Form 36 (SF‑36) questionnaire. Psy‑
chological distress symptoms were evaluated using the Hospital Anxiety Depression Score (HADS) and the Impact of 
Event Scale (IES). In‑hospital mortality rates at 3 months and 1 year were, respectively, 39.1, 50.7 and 57.2%, respec‑
tively. At 3 months, median [IQR] physical and mental component summary scores (PCS and MCS) (SF‑36) were 37 
[28–46] and 51 [45–58], respectively. PCS was lower in ICU patients with HMs when compared to general ICU septic 
patients (52 [5–13], p = 0.00001). The median combined HAD score was 8 [5–13], and the median IES score was 8 
[3–16]. However, recovery during the first year after ICU discharge was not consistent in all dimensions of HRQOL. 
Three months after ICU discharge, the maximum daily Sequential Organ Failure Assessment score and status of the 
underlying malignancy at ICU admission were significantly associated with MCS impairment (− 0.54 points [95% CI 
− 0.99; − 0.1], p = 0.018 and − 4.83 points [95% CI − 8.44; − 1.22], p = 0.009, respectively).
Conclusion: HRQOL is strongly impaired in critically ill patients with HMs at 3 months and 1 year after ICU discharge. 
Organ failure and disease status are strongly associated with QOL. The kinetic evaluation of QOL at 3 months and 
1 year offers the opportunity to focus on QOL aspects that may be improved by therapeutic interventions during the 
first year after ICU discharge.
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Background
Over the last few decades, the increased intensity of 
treatments in patients with haematological malignancies 
(HMs) has translated into an improved survival rate. As 
a consequence of more aggressive chemotherapies and 
their complications, the need for patients with HMs for 
intensive care unit (ICU) support during the course of 
their disease has increased. Although outcomes of these 
patients have been fully investigated in terms of organ 
failure and mortality [1], data are scarce on health-related 
quality of life (HRQOL) in this population [2]. Long-term 
outcomes for physical and psychological factors, func-
tional status and social interactions are becoming more 
and more important both for physicians and nurses and 
for patients and their relatives. Moreover, quality-of-life 
(QOL) measurements should be considered when mak-
ing decisions on the allocation of healthcare resources.
In the ICU, HRQOL at admission has been shown to 
be inversely associated with multiple organ failure during 
hospitalization [3] and hospital mortality [4]. Moreover, 
baseline HRQOL has been shown to be correlated with 
HRQOL following discharge [5, 6]. Finally, ICU survivors 
have significantly lower QOL compared with gender- and 
age-matched general population [7]. Data on HRQOL in 
critically ill patients with HMs are scarce [2]. Given the 
importance of the underlying disease as a strong predic-
tor of HRQOL, the present study focused on critically ill 
haematological patients. We aim to assess post-ICU bur-
den and HRQOL at 3 months and 1 year after ICU dis-
charge and to identify risk factors for QOL impairment 
using the three widely used tools in this context: Short 
Form 36 (SF-36) [8, 9], Hospital Anxiety and Depression 
Scale (HADS) [10] and Impact of Event Scale (IES) [11].
Patients and methods
Description
The study was approved by the appropriate ethics com-
mittees in France and Belgium. All patients or relatives 
were informed and consented to participate in the study. 
The TRIALOH study was carried out in 17 university or 
university-affiliated centres in France and Belgium that 
belonged to a research network instituted in 2005 [1]. 
From 1 January 2010, to 1 May 2011, consecutive patients 
with HMs who were admitted to the participating ICUs 
for any reason were included.
Exclusion criteria were: complete cure of the malig-
nancy for more than 5  years, ICU admission only to 
maximize safety of a procedure and age younger than 
18 years. In each centre, we reported the ICU refusal rate 
(number of patients considered for ICU admission but 
eventually not admitted/number of patients admitted to 
the ICU throughout the study period).
Data collection
In each centre, a standardized electronic case-report 
form was used to collect the study data. All QOL-related 
data were collected prospectively. Ninety days and 1 year 
after ICU discharge, HRQOL was assessed by asking alive 
patients to complete the SF-36 questionnaire (SF-36) 
during a telephone interview by a trained social worker.
The SF-36 includes one multi-item scale that assesses 
eight health concepts: (1) limitations in physical activities 
because of health problems; (2) limitations in social activ-
ities because of physical or emotional problems; (3) limi-
tations in usual role activities because of physical health 
problems; (4) bodily pain; (5) general mental health 
(psychological distress and well-being); (6) limitations 
in usual role activities because of emotional problems; 
(7) vitality (energy and fatigue); and (8) general health 
perceptions [12]. Higher scores represent better func-
tioning, with a range from 0 to 100. Physical and mental 
summary components (PCS and MCS, respectively) con-
stitute aggregates of the eight individual dimensions and 
provide norm-based summary scores from physically and 
mentally oriented subscales. IES and HAD scale (HADS) 
are self-report instruments that assess the essential char-
acteristics associated with stress and anxiety disorders 
among patients in a non-psychiatric hospital. The HADS 
is a 14-item self-report measure of psychological distress. 
The HADS has two subscales (anxiety and depression), 
each ranging from 0 to 21. Each item is rated on a scale 
from 0 (“not at all”) to 3 (“very much”), and higher scores 
indicate greater anxiety and depression. Scores from the 
two subscales are combined into a full-scale score that is 
indicative of a clinical disorder if greater than or equal to 
12 points [13]. The IES is a widely used self-report meas-
ure of traumatic stress based on two subscales, evaluat-
ing intrusion and avoidance. Score of 33 points or more 
is described as a cut-off for a probable diagnosis of post-
traumatic syndrome disorder (PTSD) [14].
Definitions
Malignancies were considered as newly diagnosed if they 
had been diagnosed within the past 4 weeks before ICU 
admission. The sepsis-related organ failure assessment 
(SOFA) score was computed at admission then daily 
throughout the patient’s stay in the ICU; this score pro-
vides an estimate of the risk of ICU death based on organ 
dysfunction [15]. Performance status was evaluated using 
the Eastern Cooperative Oncology Group scale (ECOG). 
Fully active, able to carry on all pre-disease performance 
without restriction; restricted in physically strenuous 
activity but ambulatory and able to carry out work of a 
light or sedentary nature, e.g. light house work, office 
work; ambulatory and capable of all self-care but unable 
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to carry out any work activities; up and about more than 
50% of waking hours; capable of only limited self-care; 
confined to bed or chair more than 50% of waking hours; 
completely disabled; cannot carry on any self-care; totally 
confined to bed or chair; dead. The ECOG performance 
status and Charlson comorbidity index were determined 
at ICU admission [16, 17].
Reasons for ICU admission were recorded based on the 
main symptoms at ICU admission. Aetiologic diagnoses 
of sepsis and acute respiratory failure were made by con-
sensus by the intensivists, hematologists and consultants. 
In particular, aetiologies of pulmonary involvement were 
diagnosed based on predefined criteria [1, 18].
Statistical analysis
Continuous variables are described as medians and 
interquartile ranges (IQRs) and were compared between 
groups using the Wilcoxon’s rank-sum test. Discrete 
variables are described with counts and percentages 
and were compared using Fisher’s exact test. We report 
norm-based measurements of the SF-36 subscores (mean 
50, SD 10), after age and sex standardization using refer-
ence values for the French population [19]. SF-36 aggre-
gate components (i.e. PCS and MCS) were computed as 
recommended [8, 20] and expressed on a normalized 
scale centred on 50 representing the population norm 
(i.e. values > or < 50 reflecting values higher or lower than 
age–sex standardized French values). Missing data in the 
individual SF-36 questions were imputed using the per-
sonal mean score approach [21]. The SF-36 aggregate 
scores (PCS and MCS) were compared using Wilcoxon’s 
rank-sum test among groups defined by categorical fac-
tors in univariate analysis. Correlations between SF-36 
aggregate scores and quantitative variables were esti-
mated and tested using Spearman correlation coefficient 
(with its 95% confidence interval [95% CI], estimated by 
bootstrap with 1000 replications). Adjusted multivari-
ate models of factors associated with PCS and MCS were 
selected, using linear regression models: characteristics 
available at ICU admission associated with p values less 
than 0.2 by univariate analysis were candidates, and final 
models were selected using backward stepwise proce-
dures (based on a p value < 0.20).
SF-36 scores at 3 months versus 1 year after discharge 
from the ICU were compared using Wilcoxon’s signed-
rank test. Factors associated with the variation of SF-36 
were examined using Wilcoxon and Kruskal–Wallis tests 
(discrete variables), or using Spearman correlation coef-
ficient testing (continuous variables). Last, the age–sex 
standardized norm-based SF-36 items and aggregate 
scores in the HM cohort were compared to those of a 
sepsis cohort of 37 patients, including adult (≥ 18  years 
old) patients surviving to an ICU hospitalization for a 
septic shock without HM. These patients were recruited 
from two prospective studies on sepsis [22, 23]. Sec-
ondarily, the comparison was performed after match-
ing patients on age and sex. Factors associated with the 
IES and HADS scores were investigated with a similar 
approach, in univariate analysis.
All tests were two-sided, and p values less than .05 were 
considered significant. Analyses were performed using R 
software version 3.2.2 [24].
Results
Patients
In total, 1011 patients were included in the TRIALOH 
study. In-hospital mortality rates at 3 months and 1 year 
were 39.1, 50.7 and 57.2%, respectively. At 3 months, 278, 
271 and 269 patients completed the SF-36, HADS and 
IES forms, respectively (Fig. 1).
Table  1 shows patient characteristics of the ICU sur-
vivors. Among them, patients who did not complete the 
SF-36 form at 3  months were older and more likely to 
require renal replacement therapy than those who com-
pleted the form (p = 0.02 and p = 0.025, respectively). 
Conversely, bone marrow transplant recipients were 
more likely to complete the form at 3 months (p = 0.024) 
and 1  year (p = 0.062) (Table  1 and Additional file  1: 
Table S1). At 1 year, we did not find any other difference 
between responders and non-responders (Additional 
file 1: Table S1).
SF‑36 score at 3 months and 1 year after ICU discharge
The results of SF-36 scores at 3  months and 1  year are 
shown in Fig. 2. At 3 months, the median [IQR] age–sex 
standardized norm-based physical component summary 
score (PCS) was 37 [28–46], which corresponds to − 1.3 
SD compared to the French general population, and the 
median [IQR] mental component summary score (MCS) 
was 51 [45–58]. Median age–sex standardized MCS val-
ues were similar (0.1 SD) to those of the general popula-
tion in HMs patients (Table 2).
All subscores were not affected proportionally: while 
the median role function—physical (RP), median vital-
ity (VT) and median general health (GH) scores were 32 
[26–41], 41 [31–48] and 38 [30–48], respectively, median 
role function—emotional (RE) score, median mental 
health (MH), median social functioning (SF) and bodily 
pain (BP) scores were 54 [38–55], 53 [45–60], 51 [31–58] 
and 50 [38–62], respectively.
Evolution of these scores over time is shown in 
Fig.  2 and Table  2. MH, RE and GH scores decreased 
significantly between 3  months and 1  year after ICU 
discharge (p = 0.003, p = 0.005 and p = 0.038, respec-
tively). MCS decreased significantly between 3 months 
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and 1  year (p = 0.006). Conversely, RP increased sig-
nificantly between 3  months and 1  year (p = 0.0004). 
Performance status has been shown to be strongly cor-
related with physical role functioning and functional 
capacity [25, 26]. When considering the performance 
status as a marker of functional capacity at baseline, 
we found a decrease in functional capacity from ICU 
admission to 3 months, with partial recovery in survi-
vors at 1 year (Additional file 1: Figure S1).
Detailed answers to the question “Compared to 
1 year ago, how would you rate your health in general 
now?” (item 2 of the SF-36) are shown in Fig. 3. Among 
survivors, 42% of patients felt better than 1 year before 
and 38.6% felt worse than 1 year before.
Comparison of critically ill patients with HMs with septic 
shock patients without HMs
We then compared QOL 3  months after discharge in 
critically ill patients with HMs with QOL in critically ill 
patients with septic shock without HMs. After match-
ing for age and sex, we found that median PCS val-
ues were higher in septic shock patients than in HMs 
patients (52 [37–59] vs. 37 [29–46], p = 0.007, respec-
tively). There was no significant difference between 
Included in the study
N=1011
Non survivors 
N = 118
Lost to Follow Up and/or 
did not answer questionnaire 
N = 220
At 3 months :
Completed SF36 = 278
Completed HAD scale =271
Completed IES score = 269
Hospital survivors
N = 616
At one year :
Completed SF36 = 117
Non survivors 
N = 65
Lost to Follow Up and/or 
did not answer questionnaire
N = 96
ICU survivors
N=732
Fig. 1 Flowchart of the patient cohort over the 1 year period following intensive care unit (ICU) discharge
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HMs and septic shock survivors regarding the MCS 
aggregate of the SF-36 questionnaire (54 [45–58] vs. 
50 [45–58], p = 0.99, respectively) (Table  3). PF, RP, 
VT and SF subscores were significantly higher in sep-
tic shock patients than in HMs patients (p = 0.016, 
p = 0.007, p = 0.035 and p = 0.007, Table 3).
Factors associated with QOL
Overall, 3 months after ICU discharge, the need for inva-
sive mechanical ventilation (MV), baseline status of the 
underlying malignancy (partial or complete remission 
of the disease vs. evolutive), the need for renal replace-
ment therapy, the need for vasopressors, sedation, SOFA 
score and haematopoietic stem cell transplant were asso-
ciated with the MCS at a 20% level in univariate analysis 
(Additional file 1: Table S2); they were included as can-
didate factors in a multivariate adjusted model. After 
selection, SOFA score and baseline status of the underly-
ing malignancy remained independently associated with 
MCS impairment (− 0.54 points [95% CI − 0.99; − 0.1], 
p = 0.018 and − 4.83 points [95% CI − 8.44; − 1.22], 
p = 0.009, respectively) (Fig. 4).
The only variable associated with PCS impairment at 
3  months at a 20% level in univariate analysis was the 
Charlson index (Additional file 1: Table S3).
Of note, patients in partial or complete remission had a 
longer median time from the diagnosis of the underlying 
Table 1 Patient characteristics of  ICU survivors. Comparison between  ICU survivors who completed the  SF-36 form 
and those who did not
MDS myelodysplastic syndrome, AML acute myeloid leukaemia, ALL acute lymphocytic leukaemia, CLL chronic lymphocytic leukaemia, CML chronic myeloid 
leukaemia, BMT bone marrow transplantation, HSC haematopoietic stem cell transplant, SOFA sepsis-related organ failure assessment, ICU intensive care unit, LOS 
length of stay
Variables Hospital survivors n 
(%) or median (IQR)
Patients who did not complete the SF‑36 
form at 3 months n (%) or median (IQR)
Patients who completed the SF‑36 
form at 3 months n (%) or median 
(IQR)
p
N 616 338 (55) 278 (45)
Male 252 (41) 139 (41) 113 (41) 0.87
Age 59 (47; 68) 60 (47; 71) 58 (47; 65) 0.020
Performance status
 0–2 529 (86) 286 (85) 243 (87)
 3–4 85 (14) 50 (15) 35 (13)
Charlson index 4 (2;5) 4 (2; 6) 4 (2; 5) 0.024
Malignancies 0.68
 AML 162 (26) 82 (24) 80 (29)
 Non‑Hodgkin’s lymphoma 191 (31) 111 (33) 80 (29)
 Hodgkin’s lymphoma 18 (3) 9 (3) 9 (3)
 ALL 44 (7) 22 (7) 22 (8)
 CLL 45 (7) 24 (7) 21 (8)
 CML 14 (2) 10 (3) 4 (1)
 Myeloma 86 (14) 51 (15) 35 (13)
 Myelodysplastic syndrome 26 (4) 14 (4) 12 (4)
BMT/HSCT recipient 0.024
 Autologous 78 (13) 37 (11) 41 (15)
 Allogeneic 70 (11) 30 (9) 40 (14)
Disease status at admission 0.16
 Newly diagnosed 237 (41) 135 (42) 102 (39)
 Partial remission 46 (8) 23 (7) 23 (9)
 Complete remission 111 (19) 52 (16) 58 (23)
SOFA score 5 (3; 7) 5 (3; 7) 5 (3; 7) 0.67
Mechanical ventilation 190 (31) 111 (33) 79 (28) 0.22
Vasopressors 219 (36) 111 (33) 100 (36) 0.93
Renal replacement therapy 106 (18) 68 (21) 38 (14) 0.025
Sedation 177 (29) 100 (30) 77 (28) 0.59
ICU LOS (days) 6 (3;10) 6 (4; 10) 5 (3; 10) 0.24
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malignancy and ICU admission than patients classified 
as having an evolutive disease. Indeed, most patients in 
the latter case (57.3% of the patients classified as having 
an evolutive disease) had a newly diagnosed malignancy 
when admitted to the ICU (Additional file 1: Figure S2)
We did not find any association between these variables 
and MCS or PCS at 1 year after ICU discharge. (Univariate 
analyses are shown in Additional file 1: Tables S4 and S5.)
Post‑traumatic stress disorder
Three months after ICU discharge, 269 patients com-
pleted the IES form. The median IES score was 8 [3, 
16]. The median intrusion subscore was 3 [0; 9], and the 
median avoidance subscore was 3 [0; 8]. Overall, 22 (8%) 
patients had an IES score greater than 35 points, which is 
considered the threshold for PTSD.
Men had a higher IES score than women (10 [4–21] 
vs. 6 [1–13], respectively, p = 0.0008). The IES score was 
positively correlated with length of stay in the ICU (cor-
relation coefficient 0.14 [95% CI 0.02; 0.026], p = 0.025) 
(Additional file 1: Figure S3). By univariate analysis, ICU 
length of stay was associated with IES score at 3 months 
(Additional file 1: Table S6).
Anxiety and depression
Three months after ICU discharge, patients had a median 
combined HAD score of 8 [5–13]. Considering both the 
subscales separately, 42 patients (15.5%) had an anxiety 
score > 8 and 41 patients (15%) had a depression score 
> 8, which are considered clinical disorders.
Discussion
This prospective study is the first multicenter study 
and the largest one focusing on HRQOL in critically ill 
patients with HMs.
To analyse all aspects of QOL, we used the SF-36 form, 
which offers a detailed mental and physical QOL evalu-
ation and has been widely used and validated in ICU 
patients, the IES for post-traumatic stress syndrome 
evaluation and the HADS for evaluation of anxiety and 
depression.
In total, 1011 patients were included in the TRIALOH 
study. With a mortality rate of 50.7% (513 patients) at 
3  months, 55.8% of survivors (278 patients) completed 
the SF-36 form at 3  months. Although response rates 
vary a lot between studies in ICU, ranging from 30 to 80% 
[27, 28], our response rate is somewhat low (56% of the 
survivors) and may be explained in part by the high mor-
bidity of patients with HMs, who require multiple hospi-
talizations and treatments in the course of their disease. 
Indeed, more days spent at hospital have been associated 
with no response at follow-up [28]. Populations who are 
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M12
P = 0.051 P = 0.005
P = 0.59
P = 0.058
P = 0.0004 P = 0.003
P = 0.092P = 0.038
Fig. 2 Radar chart of the health‑related quality of life (HRQOL) at 3 
and 12 months after ICU discharge. M3, 3 months after ICU discharge; 
M12, 12 months after ICU discharge; RP, role—function physical; PF, 
physical functioning; MH, mental health; RE, role—emotional; SF, 
social functioning; VT, vitality; GH, general health; and BP, bodily pain
Table 2 SF-36 score evolution from 3 months to 1 year after ICU discharge
Scores Median (IQR) at 3 months age–sex 
standardized
Median variation (IQR) after 1 year 
evolution
p
Physical score component 37 (28; 46) 0.0 (− 5.2; 6.5) 0.38
Mental score component 51 (45; 58) − 2.9 (− 10.7; 5.3) 0.006
Physical functioning (PF) 40 (28; 51) 0.0 (− 9.2; 8.0) 0.59
Role—physical (RP) 32 (26; 41) 0.0 (0.0; 15.1) 0.0004
Bodily pain (BP) 50 (38; 62) − 2.1 (− 10.2; 5.6) 0.051
General health (GH) 38 (30; 48) − 2.7 (− 12.6; 5.3) 0.038
Vitality (VT) 41 (31; 48) 2.7 (− 5.7; 11.0) 0.058
Social functioning (SF) 51 (31; 58) 0.0 (− 15.6; 10.7) 0.092
Role—emotional (RE) 54 (38; 55) 0.0 (− 19.1; 0.0) 0.005
Mental health (MH) 53 (45; 60) − 2.4 (− 9.6; 2.3) 0.003
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lost to follow-up or did not answer the questionnaire 
may have different demographic characteristics and dif-
ferent profiles of ICU-related morbidity than those who 
completed the QOL evaluation. Indeed, we found that 
age and the need for replacement therapy during ICU 
stay were 2 factors associated with the inability/refusal 
to complete the form. Different methods have been used 
during the study to improve response rates, such as send-
ing hand written letters and employing reminders to the 
patients.
Compared with general ICU patients with septic shock, 
critically ill patients with HMs have profound alterations 
of HRQOL at 3  months. Moreover, although RP values 
improved at 1 year, global QOL impairment was consoli-
dated at 1 year.
In a single-centre study, Oeyen et  al. [2] investigated 
long-term outcomes and QOL in critically ill patients 
with HMs (85 patients) or solid malignancies 3  months 
and 1  year after ICU discharge. Similarly, they found a 
profound alteration of QOL at 3  months and 1  year in 
HM patients with median PCS and MCS values even 
lower than those we observed in our study. Practices may 
have evolved over time, taking into account the QOL as 
an important goal when managing these patients. This 
may partly explain the discrepancy between the two 
studies.
In the present study, two main independent factors 
were significantly associated with QOL impairment 
(MCS) at 3  months: the SOFA score (i.e. organ failure) 
and the status of the underlying malignancy (complete 
or partial remission) at ICU admission. The initial SOFA 
score is used to quantify the degree of organ dysfunction 
present on admission, including the need for mechanical 
ventilation, vasopressors or renal replacement therapy. 
Many studies have demonstrated a strong correlation of 
initial SOFA score with mortality outcome [15, 29, 30]. 
In our study, we have moved a step further, presenting 
SOFA score as a reliable predictor of QOL after ICU dis-
charge. Combes et  al. [31] previously showed that pro-
longed invasive mechanical ventilation is associated with 
impaired HRQOL compared with that of a matched gen-
eral population. Noninvasive strategies during ICU stay, 
such as decreasing the use of mechanical ventilation by 
0
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P
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Fig. 3 Item 2 of the SF‑36 “Compared to 1 year ago, how would you 
rate your health in general now?”
Table 3 Components of  the  Medical Outcome Study SF-36 questionnaire for  critically ill patients with  haematological 
malignancies (HMs) and septic shock patients without HM
a SF36 values are centred around 50 (i.e. values > or < 50 reflect values higher or lower than age–sex standardized values in the general French population)
b SF36 values are centred around 0 (i.e. values > or < 0 reflect values higher or lower than age–sex standardized French values in the general French population, in 
standard deviation unit)
HM median (IQR) age–sex  standardizeda  SDb Septic shock median (IQR) age–sex 
 standardizeda  SDb
p
N 37 37
Age 52 (37; 64) 53 (37; 62)
Sex (female) 23 (62) 23 (62)
Physical functioning (PF) 43 (30; 54) − 0.7 (− 2.0; 0.4) 50 (43; 56) 0.0 (− 0.7; 0.6) 0.015
Role—physical (RP) 34 (26; 41) − 1.6 (− 2.4; − 0.9) 44 (32; 54) − 0.6 (− 1.8; 0.4) 0.007
Bodily pain (BP) 47 (37; 60) − 0.3 (− 1.3; 1.0) 57 (39; 60) 0.7 (− 1.1; 1.0) 0.34
General health (GH) 41 (33; 50) − 0.9 (− 1.7; 0.0) 41 (30; 56) − 0.9 (− 2.0; 0.6) 0.84
Vitality (VT) 41 (29; 48) − 0.9 (− 2.1; − 0.2) 48 (39; 53) − 0.2 (− 1.1; 0.3) 0.035
Social functioning (SF) 44 (28; 58) − 0.6 (− 2.2; 0.8) 54 (42; 58) 0.4 (− 0.8; 0.8) 0.042
Role—emotional (RE) 47 (37; 55) − 0.3 (− 1.3; 0.5) 54 (41; 55) 0.4 (− 0.9; 0.5) 0.48
Mental health (MH) 54 (50; 60) 0.4 (− 0.0; 1.0) 53 (45; 58) 0.3 (− 0.5; 0.8) 0.21
Physical Component Summary (PCS) 37 (29; 46) − 1.3 (− 2.1; − 0.4) 52 (37; 59) 0.2 (− 1.3; 0.9) 0.007
Mental Component Summary (MCS) 50 (45; 58) − 0.0 (− 0.5; 0.8) 54 (45; 58) 0.4 (− 0.5; 0.8) 0.99
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using high flow oxygen, when appropriate, may improve 
QOL.
SOFA score has previously been associated with 
impaired QOL in critically ill patients with acute respira-
tory distress syndrome [32]. In clinical practice, a crucial 
question is “for which critically ill HMs patients should 
we propose a limitation or withdrawal of life-sustaining 
treatments”? Decisions on withholding/withdrawing 
therapies should take into account the expected QOL 
after ICU discharge; the primary goal of intensive care 
being to return to a quality of life the patient would have 
found acceptable. Considering the SOFA score at admis-
sion as a predictor of both mortality and QOL, it may be 
helpful to physicians to inform patients and families in a 
reliable way and to guide in treatment decisions.
Paradoxically, disease status (partial or complete remis-
sion) at ICU admission was also associated with MCS 
impairment at 3 months. Patients in partial or complete 
remission have previously received intensive and poten-
tially gruelling treatments for their underlying malig-
nancy; conversely, most of patients classified as having 
an “evolutive disease” have newly diagnosed malignan-
cies when admitted to the ICU. Indeed, patients who are 
considered in partial or complete remission had a longer 
time from the diagnosis of the underlying malignancy to 
ICU admission and, overall, have therefore received more 
chemotherapy than patients with evolutive disease.
The kinetic evaluation of QOL at 3 months and 1 year 
offers the opportunity to focus on aspects of QOL that 
may be improved by therapeutic interventions during the 
first year after ICU discharge. If some aspects of QOL 
(such as RP) have improved over time, we found that 
BP, GH, MH, RE scores and MCS decreased between 
3 months and 1 year after ICU discharge. In general ICU 
populations, previous studies have shown that the major-
ity of the QOL scores recover over time [5]. Impairment 
of SF and RE suggests that patients with HMs may be 
socially isolated because of their condition. Association 
of a long hospital stay, including ICU stay and the pres-
ence of an underlying malignancy, has been shown to be 
major risk factors for social isolation [33, 34].
During hospitalization, HM patients have to deal not 
only with treatment-related complications and adverse 
events, such as physical symptoms and changes in body 
image, but also with isolation-related psychological dis-
tress, including loss of control and lack of contact with 
family members and friends. Long-term psychologi-
cal follow-up, social support and recreational activities 
during hospitalization may improve the QOL of these 
patients [34, 35]. Centres that manage haematologi-
cal patients may also consider extending visiting hours 
for relatives. Finally, bodily pain may be controlled by 
an approach carried out by a skilled pain care team and 
based on the association of causal therapies and adequate 
analgesics. PF, RP, VT and PCS are significantly lower 
in HMs patients compared with septic patients. Indeed, 
HMs and chemotherapies have been shown to induce 
a loss of weight and decrease in physical activity. Early 
mobilization in ICU and exercise may prevent the rapid 
loss of physical reserve and increase functional capacity 
[36].
In the princeps study published in 2013 by Azoulay 
et al. [1], 6 months after ICU discharge, the hematologists 
reported that all but seven ICU survivors were continu-
ing their cancer treatment that ICU admission did not 
influence therapeutic intensity in 80% of ICU survivors, 
and that 80% of ICU survivors were in complete or par-
tial remission. Unfortunately, precise data on post-ICU 
treatments are not available and we could not evaluate 
their impact on QOL.
Interestingly, only 8% of patients in our cohort were 
diagnosed with PTSD, according to the IES, which is 
lower than usually reported [37]. The use of an ICU diary 
in many participating centres may have participated 
in the low incidence of PTSD as an ICU diary has been 
associated with a significant reduction in PTSD symp-
toms in critical illness survivors [37]. A prospective mul-
ticenter comparative study of the impact of an ICU diary 
on PTSD in ICU is ongoing, involving many of the par-
ticipating centres involved in this work.
The present study has several limitations. First, we 
were unable to provide QOL measures at ICU admis-
sion. Emergent admission and critical illness prevent 
patients from providing self-reported baseline QOL at 
the time of ICU admission. Reliable retrospective QOL 
data are difficult to obtain due to memory biases follow-
ing ICU discharge. Answers to the question “Compared 
to 1 year ago, how would you rate your health in general 
now?” suggest that almost half of the patients felt better 
Fig. 4 Multivariate analysis: effects on mental component summary 
score of covariates identified by multivariate linear regression
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than 1  year before. Factors such as severity of current 
symptoms may bias patients’ recall of baseline status, 
especially in more severe patients, such as ICU patients 
[38]. Indeed, Granja et  al. [39] have shown that almost 
50% of ICU survivors did not remember the time in the 
hospital before ICU admission. Moreover, proxy assess-
ment of patients’ baseline quality of life often differs 
from the patient’s assessment [40]. Despite these limita-
tions, HRQOL impairment at ICU admission has been 
correlated with multiple organ failure during ICU stay, 
increased hospital mortality and worsened HRQOL fol-
lowing discharge [4, 6].
Second, as mentioned above, the response rate (55.8% 
of the survivors) is low, which is explained by the high 
morbidity of our population.
Third, our data are now 7  years old. Improvements 
in outcomes of cancer patients, as well as the improve-
ments in process of care may have modified the impact of 
ICU complications on HRQOL. In HM patients, several 
cohort studies and trials evaluating a noninvasive diag-
nostic and therapeutic management of acute respiratory 
failure have shown the feasibility and safety of the non-
invasive strategy [41]. High flow oxygen has also dem-
onstrated survival benefits as compared to noninvasive 
ventilation [42]. The increased use of noninvasive strate-
gies may then have improved HRQOL of these patients 
after ICU discharge.
Finally, a longer follow-up would have been interesting 
to analyse, as a gradual improvement of most aspects of 
QOL might have occurred after 1 year.
Conclusion
This study shows that HRQOL is strongly impaired in 
critically ill patients with HMs at 3  months and 1  year 
after ICU discharge. SOFA score and disease status are 
strongly correlated with QOL. Recovery after the ICU is 
not consistent in all dimensions of HRQOL. Future stud-
ies should focus on specific physical and psychosocial 
rehabilitation programs that may start in the ICU. They 
may then continue after ICU discharge and could lead to 
improved management of patients with HMs after their 
stay in the ICU.
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